Purification and characterization of an antitumor polysaccharide from Portulaca oleracea L.

In the present study, we purified a unique polysaccharide component (POP) from Portulaca oleracea and found that it had pronounced anti-tumor effects in vivo model. Tumor weight, immune organ index and T lymphocyte subsets were employed to detect the immunoregulatory and antitumor effects of POP after administration. Hematological and biochemical analyses were also investigated in order to evaluate the toxicological aspects related to POP treatment. POP could significantly inhibit the growth of transplantable sarcoma 180 and potentiate the animal's immune responses including an increase in the number of white blood cell (WBC) and CD4+ T-lymphocytes, as well as the ratio of CD4+/CD8+. Furthermore the serum aspartate transanimase (AST), alanine transaminase (ALT), urea nitrogen (BUN), and creatinine levels in S180-bearing mice were significantly reversed by POP. Considering all these results, it is suggested that the anti-tumor effect elicited by POP could be associated with its immunostimulating properties.

► We purified a unique polysaccharide component (POP) from Portulaca oleracea.
► POP had pronounced anti-tumor effects in vivo model.
► POP potentiated the animal's immune responses.
► POP protected the liver and kidney from damage.
► The anti-tumor effect of POP could be associated with its immunostimulating properties.